Akbarin Mohammad Mehdi, Farhadi Sadegh, Allahyari Abolghasem, Koshayar Mohammad Mehdi, Shirdel Abbas, Rahimi Hossein, Rezaee Seyed Abdolrahim, Mahdifar Maryam, Mozaheb Zahra, Mohamadi Asadollah, Bari Alireza, Mohaddes SeyedehTahereh, Rafatpanah Houshang
Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran.
Hematology Department, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Basic Med Sci. 2020 Aug;23(8):1007-1011. doi: 10.22038/ijbms.2020.38454.9602.
Human T cell leukaemia virus type 1 (HTLV-1) is associated with adult T cell leukaemia (ATL), a malignant lymphoproliferative disease that infects CD4 T cells. It is not clear why the majority of HTLV-1-infected individuals remain asymptomatic carries (ACs) and a minority develop ATL. Cellular immune response has a critical role in ATL and destroys malignant and HTLV-1-infected cells. Perforin and granzyme have important functional roles in apoptosis and destruction of infected cells. In the present study we examined the role of perforin and granzyme in ATL patients and ACs.
Peripheral blood mononuclear cells (PBMCs) were isolated from ATL patients and ACs by using Ficoll-hypaque density centrifugation. RNA was extracted and cDNA was synthesized. A real-time PCR TaqMan method was designed and optimized for evaluation of perforin, granzyme, tax, and HBZ gene expression. HTLV-1 proviral load (PVL) was quantified in patients with ATL and ACs.
The mRNA expression of tax and HBZ was significantly higher in ATL patients than ACs (=0.011 and =0.0001,respectively). The HTLV-1 PVL was higher in ATL patients compared to with AC group (=0.015). There was a significant increase in perforin gene expression in ACs compared with ATL patients (=0.002). Furthermore, the expression of granzyme was also higher in ACs compared with ATL patients, and significant differences were observed between the two groups (=0.036).
Low expression of perforin and granzyme in ATL patients seems to influence the efficiency of CTL function and destruction of HTLV-1-infected cells, which might contribute to the disease pathogenesis.
人类嗜T淋巴细胞病毒1型(HTLV-1)与成人T细胞白血病(ATL)相关,ATL是一种感染CD4 T细胞的恶性淋巴增殖性疾病。目前尚不清楚为何大多数HTLV-1感染者仍为无症状携带者(ACs),而少数人会发展为ATL。细胞免疫反应在ATL中起关键作用,并能破坏恶性细胞和HTLV-1感染细胞。穿孔素和颗粒酶在感染细胞的凋亡和破坏中具有重要功能作用。在本研究中,我们检测了穿孔素和颗粒酶在ATL患者和ACs中的作用。
采用Ficoll-泛影葡胺密度离心法从ATL患者和ACs中分离外周血单个核细胞(PBMCs)。提取RNA并合成cDNA。设计并优化了一种实时PCR TaqMan方法,用于评估穿孔素、颗粒酶、tax和HBZ基因的表达。对ATL患者和ACs的HTLV-1前病毒载量(PVL)进行定量。
ATL患者中tax和HBZ的mRNA表达显著高于ACs(分别为=0.011和=0.0001)。与AC组相比,ATL患者的HTLV-1 PVL更高(=0.015)。与ATL患者相比,ACs中穿孔素基因表达显著增加(=0.002)。此外,ACs中颗粒酶的表达也高于ATL患者,两组间观察到显著差异(=0.036)。
ATL患者中穿孔素和颗粒酶的低表达似乎会影响CTL功能及HTLV-1感染细胞的破坏效率,并可能导致疾病发病机制。